Directorate of Surveillance and health

GHSA - ACTION PACKAGE PREVENT 4: IMMUNIZATION

INDONESIA

Director of Surveillance and Health Quarantine Ministry of Health - Indonesia

Action Package Commitments

Action Package

Immunization (Prevent-4)

Leading Countries

Italy, Portugal

Contributing Countries

India, Pakistan, Republic of Korea, Saudi Arabia, United Arab Emirates, Yemen

GHSA Goal

Prevent

Avoidable

Epidemics

GHSA Objective

Reducing the

number and

magnitude of

infectious disease

outbreaks.

GHSA 5-Year Target

A functioning national vaccine delivery

system – with nationwide reach,

effective distributions, access for

marginalized populations,

adequate cold chain, and ongoing

quality control – that is able to respond

to new disease threats.

Indicator P.7.1 Vaccine coverage (measles) as part of National Program 1. Less than 50% 2. 50 – 69% 3. 70 – 89% 4. 90% 5. 95%

Score 4: Demonstrated capacity

Interoperable district- based

immunization information system

Low vaccination rates in small sub

population s and at risk groups

Indicator P.4.2. National Vaccines Access and Delivery

EVM in Indonesia - 2015

•

•

•

Score 5: Sustainable capacity

• Adequate funding for procurement of temperature monitoring devices Adequate quality cold chain equipment and include in the CCE Inventory EVM Self-Assessments implemented in all Provinces and Districts On-the-job training in stock management provided

www.childmortality.org 198 countries

MDG target 2015 23/1,000 LB

55,2% kematian bayidisebabkan oleh diare dan pneumonia

Diare; 31,4

Pnemonia; 23,8

Meningitis/ensefalitis; 9.3

Kelainan saluran pencernaan; 6,4

Kelainan jantung congenital dan

hidrosefalus ; 5,8

Sepsis; 4,1

Tetanus; 2,9

Malnutrisi; 2,3 TB; 1,2

Campak; 1,2

Lain-la

Infant cause of death (BHR 2007)

in; 11.6

55,2% pneumonia, diarrhoea

12.2% congernital anomalies

9.3% meningo-encephalitis

2015

34/1000 (DHS th 2007)

61/1000 LB (DHS 1991)

●

41.2%

26/1,000 LB (DHS 2012)

New Vaccine Priority

Plan 2015 2016 2017 2018 2019

Switching

tOPV to bOPV April

IPV July

MR Phase I Campaign Phase

II dan III

HPV 2 Districts in Yogyakarta

JE

JE Surveillance

8 sentinels

NRA JE Campaign

High Riks Area

PCV

Pilot project

Central Lombok

Pneumo whole cell Pilot project at 3 provinces

PCV13 Clinical Trial (BF) Pneumoccus whole cell (BF)

Rotavirus

Clinical Trial: Rota Virus 3 (RV3) (BF,

Melbourne Uni, UGM)

Pilot project

Yogyakarta and Klaten

GHSA Roadmap on

Immunization - Indonesia

2015

• Achieving 93% high quality of MCV 1

• Maintaining high OPV to be at least 95%

• Achieving at least 95% coverage of ORI and other VPDs

2016 • Addressing immunization gap for measles through Crash

Program

• IPV introduction into routine immunization

• Maintaining 100% vaccine, cold chain eq. and other logistic

2017 • Conducting antibody survey for polio after IPV

introduction • MR campaign with 95% target coverage

• At least 80% sufficient cold chain equipment

2018 • Basic health survey for DPT HepB and

Measles coverage

• MR campaign with 95% target coverage

• At least 90% sufficient cold chain equipment

2019

• Introduction MR into NIP

• Providing 100% sufficient cold

chain equipment

9

thank you